Cases 31 - 40 of 99
Brown v. LLC et al
as 3:2023cv14304
Plaintiff:
Roderick Brown
Defendant:
GlaxoSmithKline LLC, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Brown v. LLC et al
as 3:2023cv14224
Plaintiff:
Roderick Brown
Defendant:
GlaxoSmithKline LLC, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al
as 1:2023cv00926
Plaintiff:
THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC., THERAVANCE BIOPHARMA IRELAND LIMITED and others
Defendant:
EUGIA PHARMA SPECIALTIES LTD., EUGIA US LLC, AUROBINDO PHARMA USA, INC. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al
as 2:2023cv00926
Plaintiff:
THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC., THERAVANCE BIOPHARMA IRELAND LIMITED and others
Defendant:
EUGIA PHARMA SPECIALTIES LTD., EUGIA US LLC, AUROBINDO PHARMA USA, INC. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AbbVie Inc. v. Teva Pharmaceuticals, Inc. et al
as 1:2023cv00133
Plaintiff:
AbbVie Inc.
Defendant:
Teva Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
GW RESEARCH LIMITED v. TEVA PHARMACEUTICALS, INC. et al
as 2:2023cv00018
Plaintiff:
GW RESEARCH LIMITED
Defendant:
TEVA PHARMACEUTICALS, INC., APOTEX INC., PADAGIS US LLC and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
TAKEDA PHARMACEUTICALS AMERICA, INC. et al v. TEVA PHARMACEUTICALS, INC. et al
as 2:2022cv07454
Plaintiff:
TAKEDA PHARMACEUTICALS AMERICA, INC., TAKEDA PHARMACEUTICALS U.S.A., INC. and ARIAD PHARMACEUTICALS INC.
Defendant:
TEVA PHARMACEUTICALS, INC., TEVA PHARMACEUTICALS USA, INC. and TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Amicus Therapeutics US, LLC et al v. Teva Pharmaceuticals USA, Inc. et al
as 1:2022cv01461
Counter Defendant:
Amicus Therapeutics US, LLC and Amicus Therapeutics, Inc.
Counter Claimant:
Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Amicus Therapeutics US, LLC et al v. Teva Pharmaceutical Industries Ltd. et al
as 1:2022cv01462
Counter Defendant:
Amicus Therapeutics US, LLC and Amicus Therapeutics, Inc.
Counter Claimant:
Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc. and Teva Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AbbVie Inc. et al v. Alkem Laboratories Limited et al
as 1:2022cv01423
Plaintiff:
AbbVie Inc., AbbVie Ltd. and Neurocrine Biosciences, Inc.
Defendant:
Alkem Laboratories Limited, Hetero Labs Limited, Hetero Labs Limited Unit-V and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
